Log In
BCIQ
Print this Print this
 

G-Pen Mini

  Manage Alerts
Collapse Summary General Information
Company Xeris Pharmaceuticals Inc.
DescriptionMulti-dose, variable-dose pen for subcutaneous administration of room temperature-stable soluable glucagon
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationHypoglycemia
Indication DetailsTreat mild to moderate hypoglycemia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today